PATRICIA HOOD: Open Payments
NPI 1871550061 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,367 in 59 payments from 15 companies in 2025. Trend: 2023 $1,058 · 2024 $1,468 · 2025 $1,367
Food & beverage: $1,189Education: $178
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $386 |
| GENZYME CORPORATION | 12 | $279 |
| Novartis Pharmaceuticals Corporation | 7 | $151 |
| Regeneron Healthcare Solutions, Inc. | 5 | $120 |
| ABBVIE INC. | 6 | $111 |
| E.R. Squibb & Sons, L.L.C. | 5 | $96 |
| Incyte Corporation | 2 | $37 |
| UCB, Inc. | 1 | $34 |
| Lilly USA, LLC | 2 | $33 |
| LEO Pharma Inc. | 1 | $26 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Sotyktu, COSENTYX, OPZELURA, Bimzelx, TALTZ.
Industry payments across NC — which companies pay providers there.
